ScholarIQanswers from OpenAlex

RETRACTED: New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities

PaperCitations, authors & open-access status

RETRACTED: New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities is a paper indexed in ScholarIQ from OpenAlex.

How many citations does RETRACTED: New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities have?

ScholarIQcitation count

RETRACTED: New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities has 186 citations in the OpenAlex counts ScholarIQ stores.

When was RETRACTED: New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities published?

ScholarIQyear

RETRACTED: New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities has 2021 year in the ScholarIQ index.

What is the open-access status of RETRACTED: New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities?

ScholarIQoa status

RETRACTED: New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities has gold oa status in the ScholarIQ index.

What is the DOI of RETRACTED: New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities?

ScholarIQdoi

The DOI for RETRACTED: New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities is on the source record.

What is the PMID of RETRACTED: New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities?

ScholarIQpmid

The PMID for RETRACTED: New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities is on the source record.

What is the OpenAlex record for RETRACTED: New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities?

ScholarIQopenalex

The OpenAlex for RETRACTED: New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial